Corteva, Inc. (NYSE:CTVA - Get Free Report) insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Corteva Stock Up 1.9%
Shares of CTVA opened at $77.90 on Wednesday. The firm has a market capitalization of $52.39 billion, a P/E ratio of 49.31, a P/E/G ratio of 2.60 and a beta of 0.75. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $77.98. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a fifty day moving average price of $71.18 and a 200-day moving average price of $68.65.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm's revenue was down 1.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva's payout ratio is currently 45.57%.
Institutional Trading of Corteva
Several hedge funds have recently modified their holdings of CTVA. Activest Wealth Management raised its stake in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company's stock worth $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in Corteva in the third quarter valued at approximately $25,000. True Wealth Design LLC grew its holdings in Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company's stock worth $26,000 after purchasing an additional 264 shares during the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva during the second quarter worth $27,000. Finally, Garton & Associates Financial Advisors LLC acquired a new position in shares of Corteva during the fourth quarter worth $27,000. 81.54% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have weighed in on CTVA. The Goldman Sachs Group reaffirmed a "buy" rating and set a $88.00 target price on shares of Corteva in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft raised their price target on Corteva from $85.00 to $90.00 and gave the company a "buy" rating in a research note on Thursday, February 5th. Wells Fargo & Company upped their price objective on shares of Corteva from $77.00 to $85.00 and gave the stock an "overweight" rating in a research note on Thursday, February 5th. Royal Bank Of Canada raised their target price on shares of Corteva from $80.00 to $89.00 and gave the company an "outperform" rating in a research report on Thursday, February 5th. Finally, Mizuho upped their price target on shares of Corteva from $80.00 to $82.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $82.30.
Check Out Our Latest Analysis on Corteva
About Corteva
(
Get Free Report)
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
